About Our Firm
Practice Areas
Contact Us
Resource Links
What's New
Robert O'Conor, Jr.

Para la versión en español, haga clic aquí

What's New

January, 2002
All dieters who took diet pills with Fenfluramine and Dexfenfluramine, marketed as Pondimin and Redux, should take note of a ruling by the Pennsylvania Multi-District Litigation Court, which ruled early in January, 2002, that all those claimants who wanted to opt-out of the MDL 1203 Class Action Settlement have until January 3, 2003 to do so. If you took these drugs, which are now off the market since September 15, 1997, you may have a claim against the company that marketed them, American Home Products. These drugs were taken off the market because of medical evidence, since 1997, that linked the drugs to a serious form of heart disease.

The Settlement with American Home Products was for 12 Billion Dollars. This money is available to qualified claimants. However, claimants may also opt-out of the MDL 1203 Class Action to pursue their claims individually, by returning into the civil litigation system. To receive any substantial benefits from the Class Action or to be permitted to opt-out, each claimant has to meet specified medical conditions and file specific required documentation with the American Home Products Settlement Trust within the timeframe set by the MDL Court, which is before January 3, 2003.

Our firm, ROBERT O’CONOR, JR. – LAWYER is now representing claimants in this litigation. If you took these drugs, call us to discuss your rights. Should you wish to take part, we will arrange for a free echocardiogram study for you. Contact us to set up an appointment for a free consultation with our lawyers. To get more information from the FDA go to:

Chemical Right-to-Know
On the national environmental front, the Office of Pollution Prevention and Toxics is working on the "Chemical Right-to-Know Initiative" which will make available basic toxicity information on high production volume (HPV) chemical made and used in the U.S. This will increase testing of HPV chemicals that are of particular concern to children's health. For continuing updates on this vital health information source, visit the EPA home page at: http://www.epa.gov/

Drug Updates:
For special, updated reports on medical product alerts, go to the "MedWatch" section of the FDA home page: http://www.fda.gov/

About Our Firm | Attorneys | Practice Areas | Contact Us
Resource Links | What's New | Home
Robert O'Conor, Jr. is Board Certified in Personal Injury Trial Law by Texas Board of Legal Specialization; the other firm members are not certified by Texas Board of Legal Specialization.
The information provided in this Web site does not constitute legal advice for any individual or business entity; each visitor should seek the personal advice of a lawyer for his individual case. Also, the communication of any information in this firm site does not establish an attorney-client relationship between the Law Offices of Robert O'Conor, Jr. and any visitor to the site. Copyright ©2000 by Robert O'Conor, Jr. All rights reserved.